Potential of bacterial vaccines in the prevention of acute otitis media

被引：25

作者：

Eskola, J ^{[1
]}

Kilpi, T

机构：

[1] Aventis Pasteur, Lyon, France

[2] Natl Publ Hlth Inst, Helsinki, Finland

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2000年 / 19卷 / 05期

关键词：

acute otitis media; bacteria; etiology; vaccine;

D O I：

10.1097/00006454-200005001-00011

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：S72 / S78

页数：7

共 83 条

[71]

SHINEFIELD H, 1999, 17 ANN M EUR SOC PAE

[72] Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers [J].

Shinefield, HR ;

Black, S ;

Ray, P ;

Chang, I ;

Lewis, N ;

Fireman, B ;

Hackell, J ;

Paradiso, PR ;

Siber, G ;

Kohberger, R ;

Madore, DV ;

Malinowski, FJ ;

Kimura, A ;

Le, C ;

Landaw, I ;

Aguilar, J ;

Hansen, J .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (09) :757-763

[73] ROLE OF FIMBRIAE EXPRESSED BY NONTYPABLE HAEMOPHILUS-INFLUENZAE IN PATHOGENESIS OF AND PROTECTION AGAINST OTITIS-MEDIA AND RELATEDNESS OF THE FIMBRIN SUBUNIT TO OUTER-MEMBRANE PROTEIN-A [J].

SIRAKOVA, T ;

KOLATTUKUDY, PE ;

MURWIN, D ;

BILLY, J ;

LEAKE, E ;

LIM, D ;

DEMARIA, T ;

BAKALETZ, L .

INFECTION AND IMMUNITY, 1994, 62 (05) :2002-2020

[74] Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA) [J].

Talkington, DF ;

Brown, BG ;

Tharpe, JA ;

Koenig, A ;

Russell, H .

MICROBIAL PATHOGENESIS, 1996, 21 (01) :17-22

[75] Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice [J].

Tart, RC ;

McDaniel, LS ;

Ralph, BA ;

Briles, DE .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :380-386

[76]

TEELE DW, 1981, REV INFECT DIS, V3, pS113

[77] Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization [J].

VanCott, JL ;

Kobayashi, T ;

Yamamoto, M ;

Pillai, S ;

McGhee, JR ;

Kiyono, H .

VACCINE, 1996, 14 (05) :392-398

[78] Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2 [J].

Wortham, C ;

Grinberg, L ;

Kaslow, DC ;

Briles, DE ;

McDaniel, LS ;

Lees, A ;

Flora, M ;

Snapper, CM ;

Mond, JJ .

INFECTION AND IMMUNITY, 1998, 66 (04) :1513-1520

[79] Intranasal immunization of mice with PspA (Pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae [J].

Wu, HY ;

Nahm, MH ;

Guo, Y ;

Russell, MW ;

Briles, DE .

JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :839-846

[80] Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection [J].

Yamamoto, M ;

McDaniel, LS ;

Kawabata, K ;

Briles, DE ;

Jackson, RJ ;

McGhee, JR ;

Kiyono, H .

INFECTION AND IMMUNITY, 1997, 65 (02) :640-644

← 1 2 3 4 5 6 7 8 9 →